Xopenex
NDC Package 54868-4409-0
Package Information
Xopenex is levalbuterol is used to treat wheezing and shortness of breath that commonly occur with lung problems (such as asthma, chronic obstructive pulmonary disease). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-4409 and is authorized under FDA application NDA020837.
Identification & Billing
- RxCUI: 1855389 - levalbuterol HCl concentrate 1.25 MG in 0.5 ML Inhalation Solution
- RxCUI: 1855389 - levalbuterol 2.5 MG/ML Inhalation Solution
- RxCUI: 1855389 - levalbuterol HCl 1.25 MG per 0.5 ML Inhalation Solution
- RxCUI: 1855391 - Xopenex Concentrate 1.25 MG in 0.5 ML Inhalation Solution
- RxCUI: 1855391 - levalbuterol 2.5 MG/ML Inhalation Solution [Xopenex]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-4409 - Xopenex
- 54868-4409-0 - 2 POUCH in 1 CARTON / 12 VIAL in 1 POUCH / 3 mL in 1 VIAL
- 54868-4409 - Xopenex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-4409-0 identifies a specific commercial package of 2 pouch in 1 carton / 12 vial in 1 pouch / 3 ml in 1 vial of Xopenex, labeled by Physicians Total Care, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on December 18, 2000. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Levalbuterol is used to treat wheezing and shortness of breath that commonly occur with lung problems (such as asthma, chronic obstructive pulmonary disease). It is a quick-relief drug. Controlling these symptoms can decrease time lost from work or school. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily.
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868440900. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
